Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors by Josefine Kjaer, MD, Thomas E. Clancy, MD, Anders Thornell, MD, PhD, Niklas Andersson, MD, Per Hellman, MD, PhD, Joakim Crona, MD, PhD, Staffan Welin, MD, PhD, Megan Sulciner, MD, Brittany Powell, MD, Lauren Brais, MPH, Kristina Astone, MPH, William Baddoo, BA, Gerhard Doherty, MD, Jennifer A. Chan, MD, MPH, Olov Norlén, MD, PhD, Peter Stålberg, MD, PhD

Get full text